6.2 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD)
Key Takeaways
- Moisture-Associated Skin Damage (MASD) encompasses four primary clinical forms: Incontinence-Associated Dermatitis (IAD), Intertriginous Dermatitis (ITD), Peristomal MASD, and Periwound MASD.
- Differential diagnosis between IAD and pressure injuries is critical: IAD presents as diffuse, non-uniform erythema with superficial epidermal erosion in skin folds/buttocks without necrotic slough, whereas Stage 1 PI exhibits localized non-blanchable erythema over a bony prominence.
- Effective IAD prevention requires cleansing after every incontinence episode using no-rinse, pH-balanced (pH 4.5–5.5) cleansers instead of alkaline bar soaps (pH 9.0–10.0), followed by barrier application.
- Skin protectant barrier selection includes dimethicone (breathable moisture barrier), zinc oxide (thick occlusive barrier), petrolatum, and liquid cyanoacrylate/polymeric film barriers for severe skin breakdown.
- Secondary cutaneous Candida albicans superinfection in MASD presents with bright red erythema, satellite pustules/papules, and requires topical antifungal powder (nystatin or miconazole) applied under barrier ointments.
Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD)
Moisture-Associated Skin Damage (MASD) describes skin inflammation, redness, and epidermal erosion resulting from prolonged exposure of the skin to various moisture sources, including urine, liquid stool, perspiration, wound exudate, or ostomy effluent. MASD is a major clinical challenge across acute, long-term, and home care settings. Preventing and treating MASD requires accurate clinical classification, differential diagnosis from pressure injuries, structured hygiene routines, and targeted topical barrier therapy.
Etiology & Pathophysiology of MASD
The stratum corneum serves as the skin's primary physical barrier, consisting of keratin-rich corneocytes embedded in a dense lipid matrix. Prolonged moisture exposure disrupts this architectural integrity through several physiological mechanisms:
- Hyperhydration & Maceration: Excess moisture causes corneocytes to swell, disrupting cell-to-cell desmosomal attachments and lipid bilayers. Hydrated skin undergoes maceration—appearing soft, white, and wrinkled—which dramatically reduces skin tensile strength and increases vulnerability to friction and shear erosion.
- Chemical Irritation & pH Alteration: Healthy skin maintains an acidic surface coat known as the acid mantle (pH 4.5 to 5.5), which inhibits pathogen growth and regulates lipid barrier synthesis. Incontinence introduces alkaline urine and liquid fecal matter. Fecal bacteria produce urease, which converts urinary urea into ammonia, elevating skin pH ($>7.0$).
- Enzymatic Degradation: Fecal digestive enzymes—specifically pancreatic proteases (trypsin, chymotrypsin) and lipases—become highly active at elevated alkaline pH. These enzymes digest structural skin proteins and cell membrane lipids, rapidly stripping the epidermal layer.
- Frictional Damage: Macerated, chemically eroded skin contacting bed linens or diapers experiences elevated coefficients of friction, resulting in superficial epidermal stripping.
Clinical Subtypes of MASD
MASD presents in four distinct clinical forms based on moisture source and anatomical location:
- Incontinence-Associated Dermatitis (IAD): Erythema and erosion of the perineal, perianal, gluteal, groin, and inner thigh skin caused by contact with urine and/or stool.
- Intertriginous Dermatitis (ITD / Intertrigo): Inflammation occurring in opposing skin folds (inframammary, panniculus/abdominal folds, axillary, groin, toe webs) caused by trapped perspiration, elevated warmth, and skin-on-skin friction.
- Peristomal MASD: Inflammation and erosion of peristomal skin within 10 cm of an abdominal stoma (ileostomy, colostomy, urostomy) resulting from continuous contact with corrosive fecal or urinary effluent leaking beneath pouching faceplates.
- Periwound MASD: Erythema, maceration, and superficial denudation of intact skin surrounding a wound margin caused by prolonged exposure to highly volume wound exudate containing matrix metalloproteinases (MMPs).
Differential Diagnosis: IAD versus Pressure Injuries
Misidentifying IAD as a pressure injury leads to improper staging, inappropriate dressing selection, and inaccurate clinical quality metrics. Clinicians must apply systematic differential diagnostic criteria:
- Etiology: IAD is driven top-down by chemical irritation and moisture maceration; Pressure Injuries (PI) are driven bottom-up or top-down by mechanical pressure and shear forces.
- Anatomical Location: IAD occurs diffusely across perineal, gluteal cleft, thigh, and skin fold areas exposed to moisture; PIs occur specifically over distinct bony prominences (sacrum, coccyx, ischial tuberosities, heels, trochanters).
- Lesion Depth: IAD is strictly superficial (epidermis and superficial dermis erosion); PIs can extend to deep tissue, subcutaneous fat, muscle, or bone (Stage 3, Stage 4, Unstageable).
- Color & Erythema: IAD exhibits diffuse, patchy, non-uniform bright red erythema with indistinct margins; Stage 1 PIs exhibit localized, well-demarcated, non-blanchable erythema.
- Necrotic Tissue: IAD never presents with slough, eschar, or black necrotic tissue; Stage 3, Stage 4, and Unstageable PIs frequently contain yellow slough or dark eschar.
Structured Skin Hygiene & Cleansing Protocols
Preventing IAD mandates a standardized 3-step hygiene bundle: Cleanse, Protect, and Restore.
Cleansing Protocols
- Prompt Intervention: Cleanse skin immediately following every incontinent event.
- Cleanser Selection: Utilize no-rinse liquid cleansers or disposable soft cloths formulated near the skin's acidic pH (pH 4.5 to 5.5). These cleansers contain mild surfactants that encapsulate fecal matter without stripping natural skin lipids.
- Avoid Alkaline Soap: Traditional bar soaps and harsh body washes are strongly alkaline (pH 9.0 to 10.0). They dissolve the protective acid mantle, elevate skin pH, and intensify enzymatic skin destruction. Bar soap usage is strictly contraindicated for incontinence care.
- Gentle Technique: Pat or wipe skin gently with soft disposable cloths. Never scrub or rub vigorously, as mechanical friction tears fragile, macerated epidermis.
Barrier Protectants & Topical Skin Formulations
Topical skin protectants form a physical barrier against liquid, stool enzymes, and friction:
- Dimethicone (1% to 3%): Silicone-based, breathable barrier cream. Forms a hydrophobic film that repels fluid while allowing vapor evaporation. Easy to apply and reapply; ideal for mild IAD or routine prevention.
- Zinc Oxide (20% to 40%): Thick, opaque, highly protective barrier paste. Provides durable physical protection against harsh liquid fecal incontinence. Zinc oxide pastes are difficult to remove; clinicians must not scrub off remaining paste during routine cleansing. Simply clean the top layer of stool off the paste and apply a fresh layer over top.
- Petrolatum Ointment: Petroleum jelly-based occlusive barrier. Provides excellent moisture protection but can clog absorbent diaper linings (reducing diaper absorbency).
- Liquid Acrylate / Cyanoacrylate Polymeric Films: Non-stinging, solvent-free liquid barrier films or cyanoacrylate skin protectants. Form a durable, transparent, waterproof polymer layer that adheres tightly to denuded skin, lasting 48 to 72 hours. Excellent for severe, painful IAD with superficial erosion.
Management of Secondary Cutaneous Fungal Infections
The warm, moist environment of MASD and IAD frequently promotes secondary cutaneous fungal superinfections, most commonly Candida albicans.
Clinical Presentation of Cutaneous Candidiasis
- Bright, beefy-red erythema in skin folds or perineum.
- Pathognomonic Satellite Lesions: Distinct small red papules and fluid-filled pustules scattered just beyond the main advancing erythematous margin.
- Severe burning, itching (pruritus), and tenderness.
Antifungal Treatment Protocol
- Topical Antifungal Powders: Apply a thin layer of topical antifungal powder containing miconazole 2%, nystatin, or clotrimazole 1% directly to clean, dry skin folds and perineum. Gently rub the powder into the skin.
- Barrier Application over Powder: Apply a thin layer of breathable dimethicone or petrolatum barrier cream over the antifungal powder to seal the medication against the skin while repelling moisture.
- Avoid Thick Pastes: Avoid heavy zinc oxide pastes when treating active fungal infections, as thick pastes trap moisture beneath and prevent antifungal powder contact.
| Clinical Feature | Incontinence-Associated Dermatitis (IAD) | Stage 1 Pressure Injury | Stage 2 Pressure Injury |
|---|---|---|---|
| Primary Cause | Top-down chemical moisture & enzyme erosion | Bottom-up mechanical pressure & shear ischemia | Mechanical pressure, shear, or friction forces |
| Anatomical Site | Diffuse: perineum, buttocks, inner thighs, folds | Localized directly over a bony prominence | Localized over a bony prominence or device site |
| Lesion Boundaries | Diffuse, irregular, patchy, indistinct margins | Well-demarcated, distinct localized area | Well-demarcated, distinct ulcer perimeter |
| Erythema Type | Diffuse bright red; May blanch under pressure | Localized non-blanchable erythema | Non-blanchable surrounding periwound erythema |
| Depth of Tissue Loss | Superficial (epidermis/dermis erosion only) | Intact skin; no epidermal loss | Partial-thickness loss of dermis; shallow open ulcer |
| Slough / Necrotic Tissue | Absolutely absent | Absolutely absent | Absolutely absent (slough indicates Stage 3/4) |
During a skin assessment, a clinician notes diffuse, patchy, non-uniform erythema over the perineum and gluteal cleft with superficial epidermal erosion in a patient with severe fecal incontinence. The skin over the sacral bony prominence remains intact without localized discoloration. How should this lesion be classified?
Which cleansing practice is recommended to prevent skin breakdown in a patient with ongoing urinary and fecal incontinence?
A patient with severe Intertriginous Dermatitis (ITD) beneath a large abdominal panniculus exhibits bright, beefy-red skin with satellite papules and pustules expanding beyond the main erythematous border. What is the primary etiology and appropriate topical treatment for this condition?